Prostatype Genomics presents Quarterly Report
Prostatype Genomics AB has today published its quarterly report for the second quarter comprising the period from 1 April 2023 to 30 June 2023. The Company also projects that revenue growth will return to positive trend in the Third Quarter. The report is available on the company website .Quarter 2 (1 April – 30 June 2023) summarized · Net sales amounted to 56 TSEK. · Net revenue amounted to 56 TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -9 587 TSEK. · Cash flow from current operations in the